Yorke Justin W 4
4 · Processa Pharmaceuticals, Inc. · Filed Jul 24, 2023
Insider Transaction Report
Form 4
Yorke Justin W
Director
Transactions
- Exercise/Conversion
Common Stock
2023-06-27+23,636→ 56,729 total - Award
Restricted Stock
2023-06-27+101,365→ 101,365 totalExercise: $0.00→ Common Stock (101,365 underlying) - Exercise/Conversion
Restricted Stock
2023-06-27−23,636→ 0 totalExercise: $0.00→ Common Stock (23,636 underlying)
Holdings
- 519,890(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]Vesting of time-based restricted shares.
- [F2]The restricted stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders.